GlycoMark(R)(1,5 AG)

Understand what GlycoMark(R)(1,5 AG) signals

Primary unit: ug/mL
LOINC codes: 53835-5
Commercial laboratory assays: 4

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for GlycoMark(R)(1,5 AG)

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

1,5-Anhydroglucitol (1,5-AG), Intermediate Glycemic Control

Laboratory: Quest Diagnostics
Test code: 10378
Specimen: Serum
Fasting: Not stated
LOINC: 53835-5
Turnaround: Set up: Sun, Tues, Thurs-Sat

Laboratory assay overview

Diazyme 1,5-anhydroglucitol (1,5-AG) Assay is an enzymatic method intended for the quantitative determination of 1,5-anhydroglucitol (1,5-AG) in serum or plasma. The 1,5-AG Assay is for the intermediate term (preceding 1-2 weeks) monitoring of glycemic control in people with diabetes.

Quest Diagnostics population reference ranges

Quest Diagnostics calculates these statistical intervals for this specific assay and demographic group, not as universal optimal targets.

Population	Range
Age	Male (mcg/mL) \| Female (mcg/mL)
≤1 year	Not established \| Not established
2-17 years	15.0-38.0 \| 11.2-35.7
≥18 years	7.3-36.6 \| 7.5-28.4

View complete laboratory reference notes

Age | Male (mcg/mL) | Female (mcg/mL) ≤1 year | Not established | Not established 2-17 years | 15.0-38.0 | 11.2-35.7 ≥18 years | 7.3-36.6 | 7.5-28.4

Quest Diagnostics test directory, test code 10378

GlycoMark®

Laboratory: Labcorp
Test code: 500115
Specimen: Serum
Fasting: Not stated
LOINC: 53835-5
Turnaround: 3 - 5 days

Laboratory assay overview

View complete laboratory reference notes

• <18 years: Not established • Adult male: 10.7−32.0 μg/mL • Adult female: 6.8−29.3 μg/mL • Glycemic control goal for diabetic patients: >10

Labcorp test directory, test code 500115

GlycoMark® and Hb A1c

Laboratory: Labcorp
Test code: 502226
Specimen: Serum
Fasting: Not stated
Turnaround: 3 - 10 days

Laboratory assay overview

GlycoMark® testing provides an estimate of the patient's postmeal glucose during a one- to two-week period, making it ideal for intermediate term monitoring of glycemic control in diabetic patients. GlycoMark® testing can also help to monitor the effectiveness of therapeutics targeting postprandial glucose (PPG),1,2 and is a useful adjunct to routine A1c testing, because it responds more rapidly and sensitively to hyperglycemia than A1c.1,2 Hb A1c testing provides an estimate of the patient's average blood glucose over a period of two to three months. Hb A1c testing helps assess the long term diabetic control for individuals with diabetes mellitus.

View complete laboratory reference notes

GlycoMark®: • <18 years: Not established • Adult male: 10.7−32.0 μg/mL • Adult female: 6.8−29.3 μg/mL • Glycemic control goal for diabetic patients: >10 Hb A1c (percent): • Normal: <5.7% • Increased risk for diabetes: 5.7% to 6.4% • Ongoing hyperglycemia: >6.4%

Labcorp test directory, test code 502226

Hemoglobin (Hb) A1c With GlycoMark® Reflex

Laboratory: Labcorp
Test code: 503205
Specimen: Serum
Fasting: Not stated
Turnaround: 3 - 10 days

Laboratory assay overview

GlycoMark® testing provides an estimate of the patient's postmeal glucose over a one- to two-week period, making it ideal for intermediate term monitoring of glycemic control in diabetic patients. GlycoMark® testing can also help monitor the effectiveness of therapeutics targeting postprandial glucose (PPG),1,2 and it is a useful adjunct to routine A1c testing because it responds more rapidly and sensitively to hyperglycemia than A1c.1,2 Hb A1c testing provides an estimate of the patient's average blood glucose over a period of two to three months. Hb A1c testing helps assess the long term diabetic control for individuals with diabetes mellitus.

View complete laboratory reference notes

GlycoMark®: • <18 years: Not established • Adult males: 10.7−32.0 μg/mL • Adult females: 6.8−29.3 μg/mL • Glycemic control goal for diabetic patients: >10 Hemoglobin A1c (percent): • Normal: <5.7 • Increased risk for diabetes: 5.7−6.4 • Ongoing hyperglycemia: >6.4 • Estimated average glucose: − Glycemic control for adults with diabetes: <7.0 (ADA) Note: If A1c results are between 6.0 and 8.0 (including 6.0 and 8.0), GlycoMark® testing is performed. GlycoMark® reflects postprandial glucose spikes from the previous two weeks, whereas A1c reflects average glycemic control during the previous three months.

Labcorp test directory, test code 503205

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.